MUMBAI: Looks like Cipla is giving respiratory marketing a fresh breath of leadership. The company has appointed Rahul Awari as head of marketing – Cipla respiratory (associate director).
Awari shared the news on LinkedIn, calling it a promotion and thanking senior leaders for their guidance. “I’m deeply grateful for the trust reposed in me and for the leadership guidance of Pijus Mukhopadhyay, Arijit Choudhury, Rajpal Rana, Srirup Sircar and Darshan Shaha,” Cipla associate director and head of marketing Rahul Awari said.
He added that he looks forward to driving strategic growth, innovation and improved patient outcomes in respiratory care.
Awari has spent more than eight years at Cipla, moving through a series of senior marketing roles across respiratory, cardiology and ophthalmology. Most recently, he served as group brand manager for the company’s respiratory inhalation portfolio.
Before that, he led marketing initiatives for Cipla’s heart failure portfolio and played a key role in strengthening the company’s position in loop diuretics and secondary prevention therapies. According to details shared on his professional profile, he helped improve market share in loop diuretics from 70 per cent to 73 per cent through therapy-shaping initiatives.
His career in pharmaceutical marketing spans more than 16 years. Prior to Cipla, Awari worked with FDC Limited, Entod Pharmaceuticals Ltd, GSK Pharmaceuticals Ltd and Wockhardt Ltd, building experience across ophthalmology, respiratory and broader pharmaceutical portfolios.
Awari holds a Bachelor of Pharmacy degree from Dr D. Y. Patil Institute of Pharmaceutical Science, Pune, affiliated with the University of Pune.
With respiratory care remaining one of Cipla’s flagship therapy areas, the appointment signals the company’s continued focus on strengthening its leadership bench and accelerating growth in a highly competitive market.
